Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.
Kathleen M Van DykXingtao ZhouBrent J SmallJaeil AhnWanting ZhaiTim AhlesDeena GrahamPaul B JacobsenHeather JimBrenna C McDonaldKelly N H NudelmanSunita K PatelGeorge William RebeckJames C RootAndrew J SaykinHarvey Jay CohenJeanne S MandelblattJudith E CarrollPublished in: JNCI cancer spectrum (2021)
APOE ε2 polymorphisms may protect against CRCD in older breast cancer survivors receiving chemotherapy. With replication, this information could be useful for survivorship care and informing future studies of possible links to AD and defining mechanisms of protection.
Keyphrases
- cognitive decline
- community dwelling
- physical activity
- high fat diet
- middle aged
- papillary thyroid
- childhood cancer
- mild cognitive impairment
- quality improvement
- squamous cell
- current status
- white matter
- locally advanced
- radiation therapy
- skeletal muscle
- insulin resistance
- lymph node metastasis
- metabolic syndrome
- social media
- multiple sclerosis
- case control